These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7509495

  • 1. Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
    Heinrich K, Klieser E, Lehmann E, Kinzler E, Hruschka H.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):129-37. PubMed ID: 7509495
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risperidone augmentation of clozapine.
    McCarthy RH, Terkelsen KG.
    Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
    [Abstract] [Full Text] [Related]

  • 8. Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
    Lacey RL, Preskorn SH, Jerkovich GS.
    Am J Psychiatry; 1995 Sep; 152(9):1401. PubMed ID: 7544546
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM.
    Isr J Psychiatry Relat Sci; 1995 Feb; 32(1):30-7. PubMed ID: 7542642
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL, Pathiraja AP, Diamond BI, Meibach RC.
    Psychopharmacol Bull; 1992 Feb; 28(2):213-8. PubMed ID: 1381102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.